Research Article
Analyzing Dynamic Changes of Laboratory Indexes in Patients with Acute Heart Failure Based on Retrospective Study
Table 4
Management of AHF patients between different clinical outcomes.
| | Emergency treatment at admission | Control | Adverse outcome | value |
| | Diuretics, (%) | 169 (89.9) | 87 (91.6) | 0.649 | | ACEI/ARB, (%) | 85 (45.2) | 17 (17.9) | <0.001 | | Beta-blockers, (%) | 105 (55.9) | 37 (38.9) | 0.007 | | Vasoactive drugs, (%) | 63 (33.5) | 58 (61.1) | <0.001 | | Morphine, (%) | 26 (13.8) | 33 (34.7) | <0.001 | | Digoxin, (%) | 78 (41.5) | 39 (41.1) | 0.944 | | Nitrates, (%) | 120 (63.8) | 55 (57.9) | 0.332 | | Oxygen supply, (%) | 168 (89.4) | 86 (90.5) | 0.760 | | Antiasthmatic, (%) | 111 (59.0) | 58 (61.1) | 0.745 |
|
|
ACEi: angiotensin-converting enzyme inhibitor; ARB: angiotensin receptor blocker.
|
